Opendata, web and dolomites

REGIONS4PERMED SIGNED

INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REGIONS4PERMED project word cloud

Explore the words cloud of the REGIONS4PERMED project. It provides you a very rough idea of what is the project "REGIONS4PERMED" about.

regional    episodic    intervene    interregional    efforts    lacks    accelerate    investments    genomic    fragmented    manner    illness    ph    healthcare    policies    model    upstream    cutting    paradigm    molecular    stakeholder    stratifying    individuals    alone    stable    technological    regions4permed    council    shift    health    cooperation    predictive    predict    pm    joint    onset    trust    channel    drawback    medicine    size    emergent    vanguard    acute    preventive    national    huge    treatment    direct    uses    esif    action    integrate    placement    reactive    fact    functional    participatory    coordinate    nowadays    flourish    create    leap    therapies    edge    technologies    2020    fits    strengthen    innovation    care    stratify    symptoms    away    citizens    industrial    industry    leverage    stakeholders    risk    diagnostic    severe    tests    personalised    patients    investment    reinforce    deployment    link    aligning    specialisation   

Project "REGIONS4PERMED" data sheet

The following table provides information about the project.

Coordinator
FONDAZIONE TOSCANA LIFE SCIENCES 

Organization address
address: VIA FIORENTINA 1
city: SIENA
postcode: 53100
website: www.toscanalifesciences.org

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 1˙720˙000 €
 EC max contribution 1˙677˙500 € (98%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme CSA
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2022-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FONDAZIONE TOSCANA LIFE SCIENCES IT (SIENA) coordinator 587˙750.00
2    SACHSISCHES STAATSMINISTERIUM FUR WISSENSCHAFT UND KUNST DE (Dresden) participant 336˙500.00
3    FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA IT (MILANO) participant 270˙250.00
4    AXENCIA GALEGA PARA A XESTION DO CONECEMENTO EN SAUDE ES (SANTIAGO DE COMPOSTELA) participant 251˙500.00
5    Urzad Marszalkowski Wojewodztwa Dolnoslaskiego PL (Wroclaw) participant 189˙000.00
6    UNIWERSYTET MEDYCZNY IM PIASTOW SLASKICH WE WROCLAWIU PL (WROCLAW) participant 42˙500.00

Map

 Project objective

Personalised medicine (PM) represents a paradigm shift away from a ‘one size fits all’ approach to the treatment and care of patients with a particular condition, to one which uses emergent approaches in particular technological areas such as diagnostic tests, functional genomic technologies, molecular pathways (etc.) to better manage patients’ health and to target therapies. Nowadays the challenge for national and regional authorities is to enable the shift from a REACTIVE healthcare system (based on episodic and acute care model) to a PREVENTIVE (stratifying at-risk individuals and ensure that preventive action is taken to intervene well before the onset of symptoms, let alone illness) and PREDICTIVE (leverage and integrate cutting-edge technologies to not only stratify risk, but even predict risk and intervene even further upstream) system – the so called Personalised Health (PH). In the face of this potential huge leap forward, the fact that personalised health lacks the cooperation and coordination needed to organise the still very fragmented field is a severe drawback to its development and to the placement of investments in an effective manner. For this reason, it is crucial to direct major efforts towards coordinating and aligning relevant stakeholders in personalised health action across Europe and beyond; create a participatory approach; build trust; enable a multi-stakeholder process; channel investments towards Personalised Health. All this considered, Regions4PerMed will coordinate regional policies and innovation programmes in Personalised Medicine and Personalised Health to accelerate the deployment of PH for citizens and patients. The project will reinforce the cooperation between H 2020 and ESIF on PH aspects; Strengthen industrial specialisation areas in Europe and allow PH to flourish as an Emerging Industry; Enable interregional joint investment on PH, including a stable link with Vanguard Initiative and with the European Innovation Council.

 Deliverables

List of deliverables.
Advisory Board Other 2019-07-23 15:15:20
Kick-off conference Report Documents, reports 2019-07-23 15:15:21
ORDP Open Research Data Pilot 2019-07-23 15:15:14

Take a look to the deliverables list in detail:  detailed list of REGIONS4PERMED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REGIONS4PERMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REGIONS4PERMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

DIAMONDS (2020)

Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis

Read More  

STARS (2019)

Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

Read More  

HEcoPerMed (2019)

Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine

Read More